288 related articles for article (PubMed ID: 25917841)
1. Astragaloside prevents BDL-induced liver fibrosis through inhibition of notch signaling activation.
Yongping M; Zhang X; Xuewei L; Fan W; Chen J; Zhang H; Chen G; Liu C; Liu P
J Ethnopharmacol; 2015 Jul; 169():200-9. PubMed ID: 25917841
[TBL] [Abstract][Full Text] [Related]
2. [Mechanism of Astragaloside prevents cholestatic liver fibrosis through inhibition of Notch signaling activation].
Mu YP; Zhang X; Fan WW; Li XW; Chen GF; Chen JM; Zhang H; Liu P
Zhonghua Gan Zang Bing Za Zhi; 2017 Aug; 25(8):575-582. PubMed ID: 29056006
[No Abstract] [Full Text] [Related]
3. Huang Qi Decoction Prevents BDL-Induced Liver Fibrosis Through Inhibition of Notch Signaling Activation.
Zhang X; Xu Y; Chen JM; Liu C; Du GL; Zhang H; Chen GF; Jiang SL; Liu CH; Mu YP; Liu P
Am J Chin Med; 2017; 45(1):85-104. PubMed ID: 28081630
[TBL] [Abstract][Full Text] [Related]
4. Synergistic anti-liver fibrosis actions of total astragalus saponins and glycyrrhizic acid via TGF-β1/Smads signaling pathway modulation.
Zhou Y; Tong X; Ren S; Wang X; Chen J; Mu Y; Sun M; Chen G; Zhang H; Liu P
J Ethnopharmacol; 2016 Aug; 190():83-90. PubMed ID: 27282665
[TBL] [Abstract][Full Text] [Related]
5. [Notch signaling pathway participates in the differentiation of hepatic progenitor cells into bile duct epithelial cells and progression of hepatic fibrosis in cholestatic liver fibrosis rat].
Mu YP; Zhang X; Xu Y; Fan WW; Li XW; Chen JM; Chen GF; Liu P
Zhonghua Bing Li Xue Za Zhi; 2017 Jun; 46(6):400-405. PubMed ID: 28591987
[No Abstract] [Full Text] [Related]
6. Ingredients of Huangqi decoction slow biliary fibrosis progression by inhibiting the activation of the transforming growth factor-beta signaling pathway.
Du JX; Sun MY; Du GL; Li FH; Liu C; Mu YP; Chen GF; Long AH; Bian YQ; Liu J; Liu CH; Hu YY; Xu LM; Liu P
BMC Complement Altern Med; 2012 Apr; 12():33. PubMed ID: 22471627
[TBL] [Abstract][Full Text] [Related]
7. The ameliorative effect of niclosamide on bile duct ligation induced liver fibrosis via suppression of NOTCH and Wnt pathways.
Esmail MM; Saeed NM; Michel HE; El-Naga RN
Toxicol Lett; 2021 Sep; 347():23-35. PubMed ID: 33961984
[TBL] [Abstract][Full Text] [Related]
8. Astragalus saponins protect against extrahepatic and intrahepatic cholestatic liver fibrosis models by activation of farnesoid X receptor.
Zhang L; Shi J; Shen Q; Fu Y; Qi S; Wu J; Chen J; Zhang H; Mu Y; Chen G; Liu P; Liu W
J Ethnopharmacol; 2024 Jan; 318(Pt A):116833. PubMed ID: 37400008
[TBL] [Abstract][Full Text] [Related]
9. Liuweiwuling tablets attenuate BDL-induced hepatic fibrosis via modulation of TGF-β/Smad and NF-κB signaling pathways.
Liu H; Dong F; Li G; Niu M; Zhang C; Han Y; He L; Yin P; Wang B; Sang X; Li R; Wang J; Bai Z; Xiao X
J Ethnopharmacol; 2018 Jan; 210():232-241. PubMed ID: 28864168
[TBL] [Abstract][Full Text] [Related]
10. [Huangqi decoction inhibits cholangiocyte proliferation and transdifferentiation in cholestatic liver fibrosis induced by BDL in rats].
DU JX; Qiu BF; Liu P; Sun MY; Chen GF; Liu J
Zhonghua Gan Zang Bing Za Zhi; 2010 Jan; 18(1):13-8. PubMed ID: 20128962
[TBL] [Abstract][Full Text] [Related]
11. Paclitaxel alleviates liver fibrosis induced by bile duct ligation in rats: Role of TGF-β1, IL-10 and c-Myc.
Sharawy MH; Abdel-Rahman N; Megahed N; El-Awady MS
Life Sci; 2018 Oct; 211():245-251. PubMed ID: 30243650
[TBL] [Abstract][Full Text] [Related]
12. Notch signaling affects biliary fibrosis via transcriptional regulation of RBP-jκ in an animal model of chronic liver disease.
Lee SJ; Kim KH; Pak SC; Kang YN; Yoon GS; Park KK
Int J Clin Exp Pathol; 2015; 8(10):12688-97. PubMed ID: 26722458
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of notch signaling pathway prevents cholestatic liver fibrosis by decreasing the differentiation of hepatic progenitor cells into cholangiocytes.
Zhang X; Du G; Xu Y; Li X; Fan W; Chen J; Liu C; Chen G; Liu C; Zern MA; Mu Y; Liu P
Lab Invest; 2016 Mar; 96(3):350-60. PubMed ID: 26692291
[TBL] [Abstract][Full Text] [Related]
14. [Overexpression of Numb gene can inhibit the progression of biliary liver fibrosis in adult liver].
Xu YN; Xu W; Chen JM; Liu W; Chen GF; Zhang H; Liu P; Mu YP
Zhonghua Gan Zang Bing Za Zhi; 2022 Nov; 30(11):1175-1181. PubMed ID: 36891694
[No Abstract] [Full Text] [Related]
15. AICAR-Induced AMPK Activation Inhibits the Noncanonical NF-κB Pathway to Attenuate Liver Injury and Fibrosis in BDL Rats.
Zhu H; Chai Y; Dong D; Zhang N; Liu W; Ma T; Wu R; Lv Y; Hu L
Can J Gastroenterol Hepatol; 2018; 2018():6181432. PubMed ID: 30662889
[TBL] [Abstract][Full Text] [Related]
16. Vitamin D3 abates BDL-induced cholestasis and fibrosis in rats via regulating Hedgehog pathway.
Abdel-Rahman N; Sharawy MH; Megahed N; El-Awady MS
Toxicol Appl Pharmacol; 2019 Oct; 380():114697. PubMed ID: 31394158
[TBL] [Abstract][Full Text] [Related]
17. Herbal compound 861 prevents hepatic fibrosis by inhibiting the TGF-β1/Smad/SnoN pathway in bile duct-ligated rats.
Chi C; Liu XY; Hou F; Yu XZ; Li CY; Cui LJ; Liu RX; Yin CH
BMC Complement Altern Med; 2018 Feb; 18(1):52. PubMed ID: 29402324
[TBL] [Abstract][Full Text] [Related]
18. The anti-fibrotic effects of epigallocatechin-3-gallate in bile duct-ligated cholestatic rats and human hepatic stellate LX-2 cells are mediated by the PI3K/Akt/Smad pathway.
Yu DK; Zhang CX; Zhao SS; Zhang SH; Zhang H; Cai SY; Shao RG; He HW
Acta Pharmacol Sin; 2015 Apr; 36(4):473-82. PubMed ID: 25832428
[TBL] [Abstract][Full Text] [Related]
19. Reversine attenuates cholestatic ductular reaction in rats.
Huang D; Tang L; Li T; Li P; Huang Z; Weng J; Zhang S; Gu W; Huang Y
FEBS Open Bio; 2023 May; 13(5):898-911. PubMed ID: 36929584
[TBL] [Abstract][Full Text] [Related]
20. Protective effect of gastrodin on bile duct ligation-induced hepatic fibrosis in rats.
Zhao S; Li N; Zhen Y; Ge M; Li Y; Yu B; He H; Shao RG
Food Chem Toxicol; 2015 Dec; 86():202-7. PubMed ID: 26498411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
